Associate Director Biostatistics Alnylam Pharmaceuticals IncAssociate Director BiostatisticsCambridge, MA$185,300–$250,700 / yearThe Associate Director, Biostatistics is responsible for statistical activities in support of clinical trials, including contributing to trial designs, authoring statistical sections of protocols, preparing statistical analysis plans, and reviewing and interpreting the analysis of clinical trial data. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people.
Associate Director, Biostatistics Clinical Dynamix, Inc.Associate Director, BiostatisticsBurlington, MAspecific responsibilities while upholding our core working behaviors of Trust and Respect, Communication and Feedback, Accountability and Reliability, Objectivity, and Team Balance and. •Provide high-quality statistical support across clinical programs, ensuring scientific.
Director, Biostatistics Monte Rosa Therapeutics, IncDirector, BiostatisticsBoston, MassachusettsFull timeThe Director will work closely with Clinical Development and external partners to drive trial design, analysis strategies, and regulatory‑ready outputs while remaining directly involved in study‑level statistical activities. Overview: The Director of Biostatistics is a hands‑on statistical leader responsible for the design, analysis, and interpretation of Phase 1–Phase 3 clinical trials with a primary focus on inflammation and oncology indications.
Senior Manager/Associate Director, Biostatistics Beam Therapeutics IncSenior Manager/Associate Director, BiostatisticsCambridge, MA$155,000–$225,000 / yearThe ideal candidate will work closely with cross-functional study teams to provide statistical input, contribute to study-level strategy, and oversee CRO biometrics deliverables to support timely and high-quality trial execution. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.
Director or Senior Director of Biostatistics Kymera TherapeuticsDirector or Senior Director of BiostatisticsWatertown, MA$195,000–$275,000 / yearHaving advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. As the Lead Statistician, you will spearhead the statistical efforts of one or more clinical programs, playing a key role in the clinical development plan, regulatory submissions, and overall data strategy.
Senior Manager/Associate Director, Biostatistics Beam TherapeuticsSenior Manager/Associate Director, BiostatisticsCambridge, MA$155,000–$225,000 / yearThe ideal candidate will work closely with cross-functional study teams to provide statistical input, contribute to study-level strategy, and oversee CRO biometrics deliverables to support timely and high-quality trial execution. Beam's suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA.
Director Biostatistics Alnylam Pharmaceuticals IncDirector BiostatisticsCambridge, MACollaborates with Clinical Development, Regulatory and Clinical Operations Expertise Areas to design innovative clinical trials Authors the statistical sections of clinical trial protocols and statistical analysis plans Reviews and approves stratification/randomization schema Collaborates with Data Management, Clinical Development and Clinical Operations on design of eCRFs Provides statistical guidance on conduct of ongoing trials Collaborates with Statistical Programmers on summary and analysis of trial data. Leads biostatistics support for worldwide regulatory submissions Represents Alnylam in meetings with regulators, Key Opinion Leaders, partners, and other stakeholders Contributes to scientific articles, summarizing data collected in Alnylam trials Consults with Research, Preclinical, Clinical Pharmacology, Medical Affairs and Commercial colleagues on statistical questions in their work Responsible for timeline management across their clinical development program Ph.
Director, Biostatistics Monte Rosa Therapeutics IncDirector, BiostatisticsBoston, MAThe Director will work closely with Clinical Development and external partners to drive trial design, analysis strategies, and regulatory-ready outputs while remaining directly involved in study-level statistical activities. The Director of Biostatistics is a hands-on statistical leader responsible for the design, analysis, and interpretation of Phase 1-Phase 3 clinical trials with a primary focus on inflammation and oncology indications.
Senior Director, Biostatistics Sarepta Therapeutics IncSenior Director, BiostatisticsCambridge, MAFoster a culture where biostatisticians are hands-on analysts and scientific architects, not solely oversight managers, personally engaging with data exploration using modern tools (R, Python, interactive visualization) alongside traditional SAS workflows. The role requires a leader who can operate across both confirmatory and exploratory analytics - driving rigorous regulatory-grade deliverables while fostering a culture of rapid, hands-on data exploration in close partnership with clinical development.
Director, Biostatistics Tempus AI IncDirector, BiostatisticsMA$180,000–$240,000 / yearSalary Range: CHI: $180,000-$240,000 USD NYC/SF: $190,000-$260,000 The expected salary range above is applicable if the role is performed from California and may vary for other locations (Colorado, Illinois, New York). We are seeking a highly motivated and capable Director of Biostatistics to lead a team of biostatisticians involved in multiple aspects of clinical research at Tempus.
Director, Biostatistics Kymera Therapeutics IncDirector, BiostatisticsWatertown, MA$195,000–$275,000 / yearHaving advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. How you'll make an impact: As the Lead Statistician, you will spearhead the statistical efforts of a clinical program, playing a key role in the clinical development plan, regulatory submissions, and overall data strategy.
Senior Statistician II - Biostatistics AstraZeneca PlcSenior Statistician II - BiostatisticsBoston, MAThe Senior Statistician II has sufficient experience working as a statistician in the pharmaceutical industry to be working independently on activities relating to design, delivery and interpretation, regulatory submissions and/or commercialisation. The accountabilities for supporting projects directly are: Provide statistical expertise for complex design and interpretation for clinical programmes, high level internal governance committees, regulatory submissions and/or commercialisation.
NewSenior Director, Biostatistics Bicycle Therapeutics PlcSenior Director, BiostatisticsLexington, MA$235,000–$295,000 / yearThe company is evaluating nuzafatide pevedotin (formerly BT5528), a Bicycle Drug Conjugate (BDC) targeting EphA2, a historically undruggable target; a pipeline of Bicycle Radioconjugates (BRCs) and imaging agents; zelenectide pevedotin (formerly BT8009), a BDC targeting Nectin-4, a well-validated tumor antigen; and, through various partnerships, the use of Bicycle technology to develop therapies to treat diseases in a range of therapeutic areas. At Bicycle, we benefit from a hybrid style working arrangement, allowing our employees where possible the opportunity to collaborate and engage with their coworkers in person while also benefiting from the flexibility of home remote working.
Lecturer on Biostatistics Harvard UniversityLecturer on BiostatisticsCambridge, MA$135,000–$155,000 / yearOur faculty are leaders in the development of methods for the design and analysis of clinical trials and observational studies, missing data, causal inference, precision health, network analysis, computational and systems biology, microbiome analysis, statistical genetics and genomics, mental health, statistical and machine learning methods, and environmental biostatistics. The Lecturer will develop and continuously update course materials to reflect evolving methods and best practices, play an active role in coordinating instruction across the Department of Biostatistics master's programs, and contribute to educational program administration including curriculum planning and pedagogical innovation.
Executive Director Biostatistics Lantheus Holdings IncExecutive Director BiostatisticsBedford, MA$206,000–$381,000 / yearThe Executive Director will serve as the project-level biostatistician, providing expertise in the development and execution of statistical strategies, study designs, statistical analyses, and regulatory submissions for clinical development across various therapeutic areas. He/she will collaborate closely with clinical science, regulatory, and other cross-functional teams to develop clinical development plans, author key clinical, regulatory, and statistical documents, and ensure the high-quality delivery and interpretation of clinical data.
Biostatistics Associate Director (HYBRID) Vertex Pharmaceuticals IncBiostatistics Associate Director (HYBRID)Boston, MA$174,800–$262,200 / yearGeneral Summary: Biostatistics Associate Director will perform sophisticated scientific statistical analyses in support of the company's Global Medicines Development and Affairs area with minimal guidance and mentoring on new and complex issues. Develops Cross-functional Data Review (xFDR) plan, Key Reports Memo (KRM), and Data Dissemination Plan (DDP) in order to facilitate the review, summary, and dissemination of key study data/results.
Director, Biostatistics Vor BioPharma IncDirector, BiostatisticsBoston, MA$230,000–$250,000 / yearReporting to the Head of Biometrics, this individual will serve as Vors global expert in biostatistical science, with accountability for all aspects of clinical trial design, statistical methodology, regulatory submission deliverables, and cross-functional scientific partnership. Regulatory Affairs & Submission Leadership • Author and review statistical sections of regulatory documents including INDs, investigator brochures, briefing books, CSRs, and eCTD/CTD module submissions to FDA, EMA, and other health authorities.
Executive Director, Biostatistics Vertex Pharmaceuticals IncExecutive Director, BiostatisticsBoston, MA$236,000–$354,000 / yearOversees, manages, and directs multiple key projects, providing both strategic and technical expertise, and including clinical trials, observational studies, real world data (RWD) investigations, or other scientific research. General Summary: The Senior Director, Biostatistics will independently perform highly scientific statistical functions in support of a company therapeutic area or areas on new and complex issues.
Biostatistics Associate Director Vertex Pharmaceuticals IncBiostatistics Associate DirectorBoston, MA$236,000–$354,000 / yearGeneral Summary: The Associate Director, Biostatistics will perform sophisticated scientific statistical analyses in support of the company's Global Medicines Development and Affairs area with minimal guidance and mentoring on new and complex issues. At Vertex, our Total Rewards offerings also include inclusive market-leading benefits to meet our employees wherever they are in their career, financial, family and wellbeing journey while providing flexibility and resources to support their growth and aspirations.
Executive Director Biostatistics Alnylam Pharmaceuticals IncExecutive Director BiostatisticsCambridge, MA$301,800–$408,200 / yearLead the development and implementation of statistical strategies across programs including clinical trial designs, endpoint strategies, and regulatory strategies, partnering with Clinical Development and cross-functional leaders to shape development plans. The Executive Director leads a team of statisticians and works closely with cross‑functional leaders to ensure rigorous and innovative quantitative approaches to drug development.
NewAssociate Director, Biostatistics, R&D, Orion Corporation Orion CorpAssociate Director, Biostatistics, R&D, Orion CorporationBoston, MA$130,000–$300,000 / yearThe Associate Director of Biostatistics serves as a key representative of Biostatistics on cross-functional teams and contributes to the growth, development, and continuous improvement of the broader Data Sciences organization. You will join a growing oncology-focused Data Sciences function and provide strategic statistical leadership for oncology drug development programs across Phase I-III clinical development.
Exec Director, Head of Biostatistics, Biometric Sciences Viridian Therapeutics IncExec Director, Head of Biostatistics, Biometric SciencesWaltham, MAResponsibilities (including, but not limited to): Ensure that Company Research and Development projects are optimally strategized, correctly designed, properly analyzed and clearly presented to support new product development, domestic and international regulatory submissions, and life cycle management of existing products. Reporting to the SVP, Head of Biometric Sciences, the Executive Director will be responsible for managing biostatistical activities across multiple studies and programs from study start-up through study closure to ensure completion per established project team goals and objectives.
Sr. Director, Biostatistics Atavistik Bio IncSr. Director, BiostatisticsCambridge, MA$270,000–$290,000 / yearAtavistik Bio is led by an experienced team of drug hunters with a proven track record of developing marketed small molecule therapies and supported by top-tier investors, including The Column Group, Nextech Invest, Lux Capital, Regeneron Ventures, and RA Capital Management. Oversee and lead the vendor/CRO biostatistics and programming teams, including activities during TFL development, Data Monitoring Safety Board meetings, interim analyses, and database locks.
Sr. Director, Biostatistics Ipsen SASr. Director, BiostatisticsCambridge, MAIn addition, she/he will have the capacity to understand relevant multi-disciplinary knowledge and interact effectively with within the biometrics department with clinicians, regulatory affairs, medical writing, clinical operations, service/technology providers, as well data management and statistical programming. Responsible for providing strategic support to Ipsen asset team(s), as well as authoring and reviewing key study documents such as study protocol, statistical analysis plan, dataset specifications, clinical study report, publications, and regulatory submission documents.
Senior Director, Biostatistics Beeline MedicinesSenior Director, BiostatisticsBoston, MassachusettsLed by an established executive team and backed by world-class life science investors, each day Beeline Medicines is determined to bring the scientific rigor and operational excellence to get to what matters for patients – realizing a world where people with immune-mediated diseases can live life fully. Provide senior statistical leadership for assigned clinical programs — owning statistical strategy, trial design, and methodology across all phases of development (Phase I–III) and ensuring statistical approaches are scientifically rigorous, regulatorily defensible, and aligned with program objectives.
Director, Biostatistics Summit Therapeutics IncDirector, BiostatisticsCambridge, MA$203,000–$253,000 / yearHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Experience, Education and Specialized Knowledge and Skills: PhD and a minimum of 8+ years of experience or Masters (MS) and a minimum of 11+ years of experience in statistics or biostatistics or related disciplines with clinical trials, pharmaceutical/biotech industry, or healthcare experience.
Senior Director Oncology Biostatistics Bristol-Myers Squibb CoSenior Director Oncology BiostatisticsMA$279,410–$338,582 / yearThe Senior Director provides expertise and guidance in collaboration with cross-functional groups broadly across the organization in establishing study design and analyses and strategy, and institutes best practices with regards to planning, execution, interpretation and regulatory submission of clinical projects and studies. Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Biostatistics Researcher PhaseVBiostatistics ResearcherCambridge, MAResearch : Support the development of research papers for statistical, machine learning, and medical journals on modern methodological approaches relevant to the company's interests and computing platform development, as well as applied papers growing out of consulting projects or conference interactions. PhaseV is a Boston-based technology company that redefines clinical development at scale with its enterprise-ready, multi-modal AI/ML platform — accelerating decisions, de-risking trials, and driving more efficient portfolio strategies.
Director, Biostatistics Definium Therapeutics IncDirector, BiostatisticsBoston, MA$259,522–$296,557 / yearOur lead product candidate, lysergide tartrate (our proprietary orally disintegrating tablet form of lysergide (LSD) D-tartrate), represents a highly differentiated, potential best-in-class opportunity for patients suffering from generalized anxiety, major depressive disorder, and posttraumatic stress disorder. Definium Therapeutics is a late-stage clinical biopharmaceutical company and our mission is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale.
Director, Biostatistics Deciphera Pharmaceuticals IncDirector, BiostatisticsWaltham, MA$200,000–$275,000 / yearOur base salary is just one component of Deciphera's competitive total rewards strategy that also includes annual performance bonus, a long-term incentive plan, full range of benefits and other incentive compensation plans (if applicable). This individual will provide statistical strategy from early development through regulatory submission, partnering cross-functionally to drive data-informed decision-making and ensure scientific and regulatory excellence.
Director/ Senior Director, Biostatistics Cogent BiosciencesDirector/ Senior Director, BiostatisticsWaltham, MassachusettsYou will collaborate closely with partner functions—including Medical, Clinical Science, Clinical Operations, Data Management, and Statistical Programming—to support study objectives, contribute to regulatory submissions, and help drive the success of clinical development programs. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.
Senior Director Biostatistics Head of Statistical Innovation & Methodology Alnylam Pharmaceuticals IncSenior Director Biostatistics Head of Statistical Innovation & MethodologyMAMentor statisticians, promote knowledge sharing, and, as the function grows, build and lead a statistical innovation and methodology team to strengthen methodological expertise and foster a culture of statistical innovation within the Biostatistics organization. Engage externally with scientific organizations, regulatory agencies, and academic collaborators to contribute to methodological advancement, inform industry best practices, and ensure awareness of emerging statistical approaches.
Director, Biostatistics Sarepta Therapeutics IncDirector, BiostatisticsCambridge, MA$206,000–$257,500 / yearBeyond traditional SAP-driven deliverables, this role calls for a hands-on analyst who can explore data deeply, partner with clinical development to shape scientific questions, and deliver rapid insights using modern analytical tools. Leverage modern analytical tools (R, Python, interactive visualization apps) alongside SAS to accelerate data-to-insight timelines, while maintaining clear documentation and traceability of exploratory work.
Biostatistics Director (Hybrid) Vertex PharmaceuticalsBiostatistics Director (Hybrid)Boston, MassachusettsThe Director, Biostatistics will independently perform highly scientific statistical functions in support of the company’s Global Medicines Development and Affairs (GMDA) area on new and complex issues. At Vertex, our Total Rewards offerings also include inclusive market-leading benefits to meet our employees wherever they are in their career, financial, family and wellbeing journey while providing flexibility and resources to support their growth and aspirations.
NewSenior Biostatistician, Biostatistics, R&D, Orion Corporation Orion CorpSenior Biostatistician, Biostatistics, R&D, Orion CorporationBoston, MA$100,000–$180,000 / yearWith a particular focus on biomarker, translational, and precision medicine analyses, the Senior Biostatistician collaborates closely with Clinical Development, Translational Medicine, Data Sciences, Statistical Programming, and external partners to deliver high-quality statistical solutions throughout the drug development lifecycle. You will join a growing oncology-focused Data Sciences function and provide statistical support across Phase I-III oncology studies within our expanding portfolio.
Vice President, Biostatistics Remix Therapeutics IncVice President, BiostatisticsWatertown, MA$293,000–$358,000 / yearReporting to the Chief Medical Officer, you will provide executive leadership across biostatistics activities, with an initial focus on REM-422, our lead asset. Serve as a core representative in cross-functional meetings, aligning biostatistics strategy with clinical development, regulatory affairs, and quality assurance.
Sr. Director, Biostatistics ImCheck Therapeutics SASSr. Director, BiostatisticsCambridge, MAIn addition, she/he will have the capacity to understand relevant multi-disciplinary knowledge and interact effectively with within the biometrics department with clinicians, regulatory affairs, medical writing, clinical operations, service/technology providers, as well data management and statistical programming. Responsible for providing strategic support to Ipsen asset team(s), as well as authoring and reviewing key study documents such as study protocol, statistical analysis plan, dataset specifications, clinical study report, publications, and regulatory submission documents.
Associate Director, Biostatistics Summit Therapeutics IncAssociate Director, BiostatisticsCambridge, MA$190,000–$210,000 / yearHARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. Review the accuracy of clinical data, perform statistical analysis, ensure the application of appropriate statistical methods, interpret study results, and collaborate with clinical team and other team members to produce interim reports, final clinical study reports.
Director, Biostatistics Tango Therapeutics IncDirector, BiostatisticsBoston, MA$191,200–$286,800 / yearIn this new role, reporting to the Vice President, Biometrics you will be working with cross‑functional clinical teams responsible for statistical activities across Tango's clinical programs, including overseeing statistical deliverables outsourced to clinical CROs. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing.
Senior Director Biostatistics Verastem IncSenior Director BiostatisticsBoston, MA$250,000–$300,000 / yearThis role will be responsible for overseeing statistical activities for multiple clinical studies within a clinical development program, serve as a key contributor to study design and protocol development, and conceptualizing and performing analyses of clinical trial data. Your actual base salary will be based on several factors, including job-related skills, experience, internal equity, relevant education or training, location, and market dynamics.
Director, Biostatistics - Remote Agios PharmaceuticalsDirector, Biostatistics - RemoteBoston, MARemote$183,000–$275,000 / yearThe current base salary range for this position is expected to be between $183,000 and $275,000 annualized; final salary will be determined based on various factors including, but not limited to, years of relevant experience, job knowledge, skills and proficiency, degree/education, and internal comparators. The Director will serve as the lead statistician for assigned clinical development programs, leading the development and implementation of statistical solutions to support all phases of clinical trials, regulatory filing and facilitating decision-making.
NewDirector Biostatistics Neurocrine Biosciences IncDirector BiostatisticsMA$199,300–$272,000 / yearThe company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in patients with Prader-Willi syndrome, endometriosis and uterine fibroids , as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. Provides statistical leadership and strategic input to the Dev Core Team in all areas of drug development and commercialization, including the overall clinical development plan, publication planning, and studies.
Sr Dir, Biostatistics Alkermes PlcSr Dir, BiostatisticsWaltham, MARemoteIn 2024 and 2025, we were certified as a Great Place to Work in the U.S. and named one of Massachusetts' Top Places to Work by the Boston Globe, a Best Place to Work in Greater Cincinnati by the Cincinnati Business Courier and recognized as a Best Place to Work in BioPharma by Fortune Magazine. We have a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia, bipolar I disorder and narcolepsy, and a pipeline of clinical and preclinical candidates in development for various psychiatric and neurological disorders.
Global Head of Biostatistics Genentech IncGlobal Head of BiostatisticsBoston, MA$338,240–$443,940 / yearAs the Global Head of Biostatistics, you will provide strategic leadership and oversight across all Therapeutic Area (TA)-aligned Biostatistics teams, ensuring a cohesive and high-performing Biostatistics function that drives excellence in service of our strategy through study design, data analysis, and insights generation. Act as the primary liaison between the Biostatistics function and key stakeholders across Clinical, Regulatory, and Data Science teams to drive alignment and shape outcomes for shared objectives; connect key stakeholders with therapeutic area Biostatistics Leaders as nuanced questions arise.
Senior Director, Biostatistics Zenas BioPharma (USA) LLCSenior Director, BiostatisticsWaltham, MA$227,400–$284,256 / yearZenas' earlier stage programs include ZB021, a clinical-stage, potentially best-in-class, oral, IL-17AA/AF inhibitor; ZB022, a preclinical, potentially best-in-class, oral, brain-penetrant, TYK2 inhibitor; and ZB014, a preclinical half-life extended anti-CD-19 and FcRIIb monoclonal antibody. Key Responsibilities: Set biostatistical strategy for one or more clinical development programs, including clinical development plans, contribution to study trial design, analysis planning, study results presentation and interpretation, clinical study report authoring, regulatory submissions, and publications.
Director, Biostatistics Amylyx Pharmaceuticals IncDirector, BiostatisticsCambridge, MARemote$221,000–$249,000 / yearOversee and/or contribute to key statistical deliverables, including protocols, statistical analysis plans, table/listing/figure shells, clinical study reports, integrated summaries of safety and efficacy, briefing documents, regulatory responses, and submission materials. Lead the design and oversight of robust, innovative clinical trial designs that maximize probability of clinical and regulatory success, balancing scientific rigor with operational feasibility, while anticipating and proactively addressing potential regulatory challenges.
Vice President, Head of Data Science & Biostatistics Solid Biosciences IncVice President, Head of Data Science & BiostatisticsMA$288,275–$377,128 / yearSolid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich's ataxia (FA), catecholaminergic polymorphic ventricular tachycardia (CPVT), TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases. We are seeking a Vice President, Head of Data Science & Biostatistics to provide strategic and operational leadership for data sciences across late-stage clinical development for multiple Phase 3 gene trials as well as early stage clinical studies focused on neuromuscular and cardiac diseases.
NewPrincipal Statistical Programmer Vertex PharmaceuticalsPrincipal Statistical ProgrammerBoston, MassachusettsRemoteEngages with a variety of other functions, including Statistical Programmers, Biostatisticians, Data Management, and other departments engaged in providing data and submission-related activities, often at Senior Management levels. Solves complex clinical trial reporting problems and demonstrates technical proficiency and exercises judgment in supporting daily operations and ensuring that study tasks are completed accurately and in a timely manner.
NewSenior / Principal Statistical Programmer, Clinical Development Data Services, R&D, Orion Corporation Orion CorpSenior / Principal Statistical Programmer, Clinical Development Data Services, R&D, Orion CorporationBoston, MA$100,000–$180,000 / yearAs a Senior / Principal Statistical Programmer in a growing oncology-focused Data Sciences function, you are responsible for the development, validation, and delivery of clinical trial datasets, statistical outputs, and regulatory submission packages that support oncology drug development programs. Drive adoption of innovative programming approaches and AI-assisted workflows to improve efficiency, quality, and scalability of clinical trial deliverables.
Lead statistical Programmer Katalyst Healthcares & Life SciencesLead statistical ProgrammerBoston, MAThe position involves hands-on technical leadership and requires comprehensive and detailed knowledge of statistical programming languages and software, filing support, clinical trial databases, and the drug development process. The role oversees external CRO partners to ensure high-quality, timely, and compliant delivery of analysis datasets, tables, listings, and figures that support clinical development and regulatory submissions.